Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma

Cancer Research

Volumn 58, Issue 5, 1998, Pages 985-990

  Chao, Yee ^a,c   Shih, Yung Luen ^b   Chiu, Jen Hwey ^a   Chau, Gar Yang ^a   Lui, Wing Yu ^a   Yang, Wen K ^b   Lee, Shou Dong ^a   Huang, Tze Sing ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CELL PROTEIN; CYCLIN A; DNA; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; SKP 2; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN A; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECURRENCE; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 0032030883     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Chiu, S-T., Chiu, J-H., Lui, W-Y., Chau, G-Y., Loong, C-C. and Wu, C-W. Prognostic factors affecting long-term survival after partial hepatectomy for human hepatocellular carcinoma. Chin. Med. J. (Taipei), 59: 177-185, 1997.
2. Chiu, J-H., Kao, H-L., Wu, L-H., Chang, H-M., and Lui, W-Y. Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry. J. Clin. Invest., 89: 539-545, 1992.
3. Chiu, J-H., Wu, L-H., Kao, H-L., Chang, H-M., Tsay, S-H., Loong, C-C., Chau, G-Y., and Lui, W-Y. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma? Hepatology, 18: 96-102, 1993.
4. Zhang, Y-J., Jiang, W., Chen, C. J., Lee, C. S., Kahn, S. M., Santella, R. M., and Weinstein, I. B. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun., 196: 1010-1016, 1993.
5. Nishida, N., Fukuda, Y., Komeda, T., Kita, R., Sando, T., Furukawa, M., Amenomori, M., Shibagaki, I., Nakao, K., Ikenaga, M., and Ishizaki, K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res., 54: 3107-3110, 1994.
6. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
7. Hunter, T., and Pines, J. Cyclins and cancer. Cell, 66: 1071-1074, 1991.
8. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
9. Walker, D. H., and Maller, J. L. Role of the cyclin A in the dependence of mitosis on completion of DNA replication. Nature (Lond.), 345: 314-317, 1991.
10. Pagano, M., Pepperkok, R., Verde, F., Ansorge, W., and Draetta, G. Cyclin A is required at two points in the human cell cycle. EMBO J., 11: 961-971, 1992.
11. 2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA, 89: 2824-2828, 1992.
12. Giordano, A., Whyte, P., Harlow, E., Franza, B. R., Jr., Beach, D., and Draetta, G. A. A 60 kd cdc2-associated polypeptide complexes with the E1A protein in adenovirus-infected cells. Cell, 58: 981-990, 1989.
13. Pines, J., and Hunter, T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature (Lond.), 346: 760-763, 1990.
14. Faha, B., Ewen, M. E., Tsai, L. H., Livingstone, D. M., and Harlow, E. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (Washington DC), 255: 87-90, 1992.
15. Bandara, L., Adamczewski, J., Hunter, T., and La Thangue, N. Cyclin A and retinoblastoma gene product complex with a common transcription factor. Nature (Lond.), 352: 249-251, 1991.
16. Mudryj, M., Devoto, S., Hiebert, S., Hunter, T., Pines, J., and Nevins, J. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell, 65: 1243-1253, 1991.
17. Shirodkar, S., Ewen, M. E., DeCaprio, J., Morgan, J., Livingstone, D. M., and Chittenden, T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle regulated manner. Cell, 69: 157-166, 1992.
18. Xu, M., Sheppard, C-Y., Peng, C-Y., Yee, A. S., and Piwnica-Worms, H. Cyclin A/CDK2 binds directly to E2F and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Biol. Cell, 14: 8420-8431, 1994.
19. Paterlini, P., Flejou, J-F., De Mitri, M. S., Pisi, E., Franco, D., and Brechot, C. Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. J. Hepatol., 23: 47-52, 1995.
20. De Mitri, M. S., Pisi, E., Brechot, C., and Paterlini, P. Low frequency of allelic loss in the cyclin A gene in human hepatocellular carcinomas: a study based on PCR. Liver, 13: 259-261, 1993.
21. Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell, 82: 915-925, 1995.
22. Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., and Elledge, S. J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell, 86: 263-274, 1996.
23. Connelly, C., and Hieter, P. Budding yeast SKP1 encodes an evolutionarily conserved kinetochore protein required for cell cycle progression. Cell. 86: 275-285, 1996.
24. Huang, T-S., Yang, W. K., and Whang-Peng, J. GL331-induced disruption of cyclin B1/CDC 2 complex and inhibition of CDC 2 kinase activity. Apoptosis, 1: 213-217, 1996.
25. 1-S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents. Oncogene, 13: 625-632, 1996.
26. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
27. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
28. Cox, D. R. Regression models and life-tables (with discussion). J. Royal Statist. Soc. B, 34: 187-220, 1972.
29. Girard, F., Strausfeld, U., Fernandez, A., and Lamb, N. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell, 67: 1169-1179, 1991.
30. Zindy, F., Lamas, E., Chenivesse, X., Sobczak, J., Wang, J., Fosquet, D., Henglein, B., and Brechot, C. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun., 182: 1144-1154, 1992.
31. kip1. Mol. Cell. Biol., 15: 4347-4352, 1995.
32. Krude, T., Jackman, M., Pines, J., and Laskey, R. A. Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell, 88: 109-119, 1997.
33. Wang, J., Chenivesse, X., Henglein, B., and Brechot, C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature (Lond.), 343: 555-557, 1990.
34. Wang, J., Zindy, F., Chenivesse, X., Lamas, E., Henglein, B., and Brechot, C. Modification of a cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma. Oncogene, 7: 1653-1656, 1992.
35. Dutta, A., and Stillmann, B. Cdc2 family kinases phosphorylate a human cell DNA replication factor, RPA, and activate DNA replication. EMBO J., 11: 2189-2199, 1992.
36. Xiong, Y., Zhang, H., and Beach, D. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 7: 1572-1583, 1993.
37. cdk2 is a component of the E2F-cyclin A complex. Cell, 68: 167-176, 1992.
38. Pagano, M., Draetta, G., and Jansen-Durr, P. Association of cdk-2 kinase with the transcription factor E2F during S-phase. Science (Washington DC), 255: 1144-1147, 1992.
39. Dou, Q. P. Putative roles of retinoblastoma protein in apoptosis. Apoptosis, 2: 5-18, 1997.
40. Volm, M., Koomagi, R., Mattern, J., and Stammler, G. Cyclin A is associated with an unfavorable outcome in patients with non-small-cell lung carcinomas. Br. J. Cancer, 75: 1774-1778, 1997.